Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Longleaf Partners Fund reports flat performance for 3Q25 (-0.33% return vs. 8.12% for the S&P 500), actively trailing the frothy index during the late-stages of a bull market. The manager provides...
— Southeastern Asset Management, Inc.
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Bio-Rad Laboratories Inc.
Bio-Rad was repurchased by the fund because of its dominant market share in key life science categories and diversified global footprint. The company has...
Bio-Rad is a highly integrated leader in specialized niches of diagnostics and life sciences, benefiting from high barriers to entry and strong recurring revenue. The company possesses...
The manager initiated a new position in Bio-Rad, citing its diversified global customer base and strong financial profile. The company features...